Human ENPP-1 Protein 3407

$330.00 – $1,100.00

Summary

Expression: HEK293
Active: Yes (catalytic)
Amino Acid Range: Lys98-Asp925

SKU: 3407parent Categories: proteins, Recombinant proteins Tag: active proteins

Weight	1 lbs
Dimensions	9 × 5 × 2 in
accession	P22413
express system	HEK293
product tag	C-His
purity	> 95% as determined by Tris-Bis PAGE
background	Ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 is a membrane-bound protein that catalyzes the hydrolysis of extracellular nucleoside triphosphates to monophosphate and extracellular inorganic pyrophosphate (ePPi). Mechanical stimulation regulates ENPP-1 expression.
molecular weight	The protein has a predicted MW of 96.5 kDa. Due to glycosylation, the protein migrates to 110-115 kDa based on Tris-Bis PAGE result.
available size	100 µg, 500 µg
endotoxin	Less than 1EU per μg by the LAL method.

Human ENPP-1 Protein 3407

protein

Size and concentration 100, 500µg and lyophilized
Form Lyophilized
Storage Instructions Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Storage buffer Shipped at ambient temperature.
Purity > 95% as determined by Tris-Bis PAGE

target relevance
Ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 is a membrane-bound protein that catalyzes the hydrolysis of extracellular nucleoside triphosphates to monophosphate and extracellular inorganic pyrophosphate (ePPi). Mechanical stimulation regulates ENPP-1 expression.
Protein names Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) (Membrane component chromosome 6 surface marker 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) [Cleaved into: Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form] [Includes: Alkaline phosph
Gene names ENPP1,ENPP1 M6S1 NPPS PC1 PDNP1
Protein family Nucleotide pyrophosphatase/phosphodiesterase family
Mass 9606Da
Function Nucleotide pyrophosphatase that generates diphosphate (PPi) and functions in bone mineralization and soft tissue calcification by regulating pyrophosphate levels (By similarity). PPi inhibits bone mineralization and soft tissue calcification by binding to nascent hydroxyapatite crystals, thereby preventing further growth of these crystals (PubMed:11004006). Preferentially hydrolyzes ATP, but can also hydrolyze other nucleoside 5' triphosphates such as GTP, CTP and UTP to their corresponding monophosphates with release of pyrophosphate, as well as diadenosine polyphosphates, and also 3',5'-cAMP to AMP (PubMed:25344812, PubMed:27467858, PubMed:28011303, PubMed:35147247, PubMed:8001561). May also be involved in the regulation of the availability of nucleotide sugars in the endoplasmic reticulum and Golgi, and the regulation of purinergic signaling (PubMed:27467858, PubMed:8001561). Inhibits ectopic joint calcification and maintains articular chondrocytes by repressing hedgehog signaling; it is however unclear whether hedgehog inhibition is direct or indirect (By similarity). Appears to modulate insulin sensitivity and function (PubMed:10615944). Also involved in melanogenesis (PubMed:28964717). Also able to hydrolyze 2',3'-cGAMP (cyclic GMP-AMP), a second messenger that activates TMEM173/STING and triggers type-I interferon production (PubMed:25344812). 2',3'-cGAMP degradation takes place in the lumen or extracellular space, and not in the cytosol where it is produced; the role of 2',3'-cGAMP hydrolysis is therefore unclear (PubMed:25344812). Not able to hydrolyze the 2',3'-cGAMP linkage isomer 3'-3'-cGAMP (PubMed:25344812).
Catalytic activity BINDING 218; /ligand="AMP"; /ligand_id="ChEBI:CHEBI:456215"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 218; /ligand="Zn(2+)"; /ligand_id="ChEBI:CHEBI:29105"; /ligand_label="1"; /ligand_note="catalytic"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 256; /ligand="AMP"; /ligand_id="ChEBI:CHEBI:456215"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 256; /ligand="CMP"; /ligand_id="ChEBI:CHEBI:60377"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 256; /ligand="dTMP"; /ligand_id="ChEBI:CHEBI:63528"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 256; /ligand="GMP"; /ligand_id="ChEBI:CHEBI:58115"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 256; /ligand="Zn(2+)"; /ligand_id="ChEBI:CHEBI:29105"; /ligand_label="1"; /ligand_note="catalytic"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 277; /ligand="AMP"; /ligand_id="ChEBI:CHEBI:456215"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 277; /ligand="CMP"; /ligand_id="ChEBI:CHEBI:60377"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 277; /ligand="dTMP"; /ligand_id="ChEBI:CHEBI:63528"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 277; /ligand="GMP"; /ligand_id="ChEBI:CHEBI:58115"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 290; /ligand="GMP"; /ligand_id="ChEBI:CHEBI:58115"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 295; /ligand="AMP"; /ligand_id="ChEBI:CHEBI:456215"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 295; /ligand="CMP"; /ligand_id="ChEBI:CHEBI:60377"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 295; /ligand="GMP"; /ligand_id="ChEBI:CHEBI:58115"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 340; /ligand="AMP"; /ligand_id="ChEBI:CHEBI:456215"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 340; /ligand="CMP"; /ligand_id="ChEBI:CHEBI:60377"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 340; /ligand="dTMP"; /ligand_id="ChEBI:CHEBI:63528"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 340; /ligand="GMP"; /ligand_id="ChEBI:CHEBI:58115"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 376; /ligand="AMP"; /ligand_id="ChEBI:CHEBI:456215"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 376; /ligand="CMP"; /ligand_id="ChEBI:CHEBI:60377"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 376; /ligand="dTMP"; /ligand_id="ChEBI:CHEBI:63528"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 376; /ligand="GMP"; /ligand_id="ChEBI:CHEBI:58115"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 376; /ligand="Zn(2+)"; /ligand_id="ChEBI:CHEBI:29105"; /ligand_label="2"; /ligand_note="catalytic"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 380; /ligand="2',3'-cGAMP"; /ligand_id="ChEBI:CHEBI:143093"; /ligand_note="substrate"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 380; /ligand="Zn(2+)"; /ligand_id="ChEBI:CHEBI:29105"; /ligand_label="2"; /ligand_note="catalytic"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 423; /ligand="Zn(2+)"; /ligand_id="ChEBI:CHEBI:29105"; /ligand_label="1"; /ligand_note="catalytic"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 424; /ligand="AMP"; /ligand_id="ChEBI:CHEBI:456215"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 424; /ligand="CMP"; /ligand_id="ChEBI:CHEBI:60377"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 424; /ligand="dTMP"; /ligand_id="ChEBI:CHEBI:63528"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 424; /ligand="GMP"; /ligand_id="ChEBI:CHEBI:58115"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 424; /ligand="Zn(2+)"; /ligand_id="ChEBI:CHEBI:29105"; /ligand_label="1"; /ligand_note="catalytic"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 532; /ligand="2',3'-cGAMP"; /ligand_id="ChEBI:CHEBI:143093"; /ligand_note="substrate"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 535; /ligand="AMP"; /ligand_id="ChEBI:CHEBI:456215"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 535; /ligand="CMP"; /ligand_id="ChEBI:CHEBI:60377"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 535; /ligand="dTMP"; /ligand_id="ChEBI:CHEBI:63528"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 535; /ligand="GMP"; /ligand_id="ChEBI:CHEBI:58115"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 535; /ligand="Zn(2+)"; /ligand_id="ChEBI:CHEBI:29105"; /ligand_label="2"; /ligand_note="catalytic"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 800; /ligand="Ca(2+)"; /ligand_id="ChEBI:CHEBI:29108"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 802; /ligand="Ca(2+)"; /ligand_id="ChEBI:CHEBI:29108"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 804; /ligand="Ca(2+)"; /ligand_id="ChEBI:CHEBI:29108"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 806; /ligand="Ca(2+)"; /ligand_id="ChEBI:CHEBI:29108"; /evidence="ECO:0000250\|UniProtKB:P06802"; BINDING 808; /ligand="Ca(2+)"; /ligand_id="ChEBI:CHEBI:29108"; /evidence="ECO:0000250\|UniProtKB:P06802"
Subellular location [Ectonucleotide pyrophosphatase/phosphodiesterase family member 1]: Cell membrane ; Single-pass type II membrane protein. Basolateral cell membrane ; Single-pass type II membrane protein. Note=Targeted to the basolateral membrane in polarized epithelial cells and in hepatocytes, and to matrix vesicles in osteoblasts (PubMed:11598187). In bile duct cells and cancer cells, located to the apical cytoplasmic side (PubMed:11598187).; [Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form]: Secreted. Note=Secreted following proteolytic cleavage.
Tissues Expressed in plasma cells and also in a number of non-lymphoid tissues, including the distal convoluted tubule of the kidney, chondrocytes and epididymis (PubMed:9344668). Expressed in melanocytes but not in keratinocytes (PubMed:28964717).
Structure [Ectonucleotide pyrophosphatase/phosphodiesterase family member 1]: Homodimer (PubMed:28964717). Interacts with INSR; leading to inhibit INSR autophosphorylation and subsequent activation of INSR kinase activity (PubMed:10615944).; [Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form]: Monomeric (By similarity).
Post-translational modification Autophosphorylated as part of the catalytic cycle of phosphodiesterase/pyrophosphatase activity.; N-glycosylated.; The secreted form is produced through cleavage at Lys-103 by intracellular processing.
Domain Th
Target Relevance information above includes information from UniProt accession: P22413
The UniProt Consortium